MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1517/14656566.9.12.2077

Медицинская библиотека · Expert opinion on pharmacotherapy · 2008

Emerging therapeutic regimes for the management of mycetomas.

Ameen Mahreen, Arenas Roberto

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

Mycetomas are chronic, granulomatous, subcutaneous infections caused by either actinomycetes bacteria or eumycetes fungi. The disease is endemic in the tropics and is characterised by a slow progression with risks of bone and visceral involvement. Therapy has consisted of prolonged courses of antibiotics or antifungals, often combined with surgery. The long treatment duration, poor therapy response and high rates of relapse have prompted trials of novel antibiotics and antifungals.

OBJECTIVE

The aim of this study was to describe recent advances and developments in the diagnosis, prognosis and treatment of mycetomas.

METHODS

An extensive review of the literature was conducted into all aspects of the management of mycetomas, with a particular focus on novel drug therapy regimes.

RESULTS/

CONCLUSION

There have been notable advances in improved molecular techniques for species identification. Carbapenems, oxazolidinones and triazoles have emerged as promising therapeutic options, but access to drug therapies in developing countries remains limited by the poor availability and high costs.

Для цитирования: Ameen Mahreen, Arenas Roberto. Emerging therapeutic regimes for the management of mycetomas.. Expert opinion on pharmacotherapy. 2008. DOI: 10.1517/14656566.9.12.2077.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.